475 related articles for article (PubMed ID: 31085181)
1. Ischemic ventricular tachycardia from below the posteromedial papillary muscle, a particular entity: Substrate characterization and challenges for catheter ablation.
Enriquez A; Briceno D; Tapias C; Shirai Y; Muser D; Liang J; Hayashi T; Santangeli P; Frankel DS; Supple GE; Schaller RD; Arkles J; Rodriguez D; Callans DJ; Marchlinski FE; Saenz L; Garcia FC
Heart Rhythm; 2019 Aug; 16(8):1174-1181. PubMed ID: 31085181
[TBL] [Abstract][Full Text] [Related]
2. Exit sites on the epicardium rarely subtend critical diastolic path of ischemic VT on the endocardium: Implications for noninvasive ablation.
Bhaskaran A; Nayyar S; Porta-Sánchez A; Haldar S; Bokhari M; Massé S; Liang T; Zehra N; Farid T; Downar E; Nanthakumar K
J Cardiovasc Electrophysiol; 2019 Apr; 30(4):520-527. PubMed ID: 30614114
[TBL] [Abstract][Full Text] [Related]
3. Catheter ablation for ventricular tachycardia after failed endocardial ablation: epicardial substrate or inappropriate endocardial ablation?
Schmidt B; Chun KR; Baensch D; Antz M; Koektuerk B; Tilz RR; Metzner A; Ouyang F; Kuck KH
Heart Rhythm; 2010 Dec; 7(12):1746-52. PubMed ID: 20709191
[TBL] [Abstract][Full Text] [Related]
4. Hybrid Ventricular Tachycardia Ablation after Failed Percutaneous Endocardial and Epicardial Ablation.
Haanschoten DM; Adiyaman A; Smit JJJ; Delnoy PPHM; Ramdat Misier AR; Porta F; Storm van Leeuwen RPH; Elvan A
Cardiology; 2020; 145(2):88-94. PubMed ID: 31707389
[TBL] [Abstract][Full Text] [Related]
5. Endo-epicardial versus only-endocardial ablation as a first line strategy for the treatment of ventricular tachycardia in patients with ischemic heart disease.
Izquierdo M; Sánchez-Gómez JM; Ferrero de Loma-Osorio A; Martínez A; Bellver A; Peláez A; Núñez J; Núñez C; Chorro J; Ruiz-Granell R
Circ Arrhythm Electrophysiol; 2015 Aug; 8(4):882-9. PubMed ID: 26056239
[TBL] [Abstract][Full Text] [Related]
6. Epicardial substrate and outcome with epicardial ablation of ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy/dysplasia.
Garcia FC; Bazan V; Zado ES; Ren JF; Marchlinski FE
Circulation; 2009 Aug; 120(5):366-75. PubMed ID: 19620503
[TBL] [Abstract][Full Text] [Related]
7. Epicardial ventricular tachycardia in ischemic cardiomyopathy: Prevalence, electrophysiological characteristics, and long-term ablation outcomes.
Hayashi T; Liang JJ; Muser D; Shirai Y; Enriquez A; Garcia FC; Supple GE; Schaller RD; Frankel DS; Lin D; Nazarian S; Zado ES; Arkles JS; Dixit S; Callans DJ; Marchlinski FE; Santangeli P
J Cardiovasc Electrophysiol; 2018 Nov; 29(11):1530-1539. PubMed ID: 30230120
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the epicardial substrate for catheter ablation of Brugada syndrome.
Zhang P; Tung R; Zhang Z; Sheng X; Liu Q; Jiang R; Sun Y; Chen S; Yu L; Ye Y; Fu G; Shivkumar K; Jiang C
Heart Rhythm; 2016 Nov; 13(11):2151-2158. PubMed ID: 27453126
[TBL] [Abstract][Full Text] [Related]
9. Endocardial ablation to eliminate epicardial arrhythmia substrate in scar-related ventricular tachycardia.
Komatsu Y; Daly M; Sacher F; Cochet H; Denis A; Derval N; Jesel L; Zellerhoff S; Lim HS; Jadidi A; Nault I; Shah A; Roten L; Pascale P; Scherr D; Aurillac-Lavignolle V; Hocini M; Haïssaguerre M; Jaïs P
J Am Coll Cardiol; 2014 Apr; 63(14):1416-26. PubMed ID: 24486269
[TBL] [Abstract][Full Text] [Related]
10. Catheter ablation of ventricular tachycardia in ischemic cardiomyopathy: Impact of concomitant amiodarone therapy on short- and long-term clinical outcomes.
Di Biase L; Romero J; Du X; Mohanty S; Trivedi C; Della Rocca DG; Patel K; Sanchez J; Yang R; Alviz I; Mohanty P; Gianni C; Tarantino N; Zhang XD; Horton R; Al-Ahmad A; Lakkireddy D; Burkhardt DJ; Chen M; Natale A
Heart Rhythm; 2021 Jun; 18(6):885-893. PubMed ID: 33592323
[TBL] [Abstract][Full Text] [Related]
11. Substrate Characterization and Outcome of Catheter Ablation of Ventricular Tachycardia in Patients With Nonischemic Cardiomyopathy and Isolated Epicardial Scar.
Liuba I; Muser D; Chahal A; Tschabrunn C; Santangeli P; Kuo L; Frankel DS; Callans DJ; Garcia F; Supple GE; Schaller RD; Dixit S; Lin D; Nazarian S; Kumareswaran R; Arkles J; Riley MP; Hyman MC; Walsh K; Guandalini G; Arceluz M; Pothineni NVK; Zado ES; Marchlinski F
Circ Arrhythm Electrophysiol; 2021 Dec; 14(12):e010279. PubMed ID: 34847692
[TBL] [Abstract][Full Text] [Related]
12. Noninvasive epicardial and endocardial electrocardiographic imaging of scar-related ventricular tachycardia.
Wang L; Gharbia OA; Horáček BM; Sapp JL
J Electrocardiol; 2016; 49(6):887-893. PubMed ID: 27968777
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of combined endocardial/epicardial catheter ablation for ventricular tachycardia in Chagas disease: A randomized controlled study.
Pisani CF; Romero J; Lara S; Hardy C; Chokr M; Sacilotto L; Wu TC; Darrieux F; Hachul D; Kalil-Filho R; Di Biase L; Scanavacca M
Heart Rhythm; 2020 Sep; 17(9):1510-1518. PubMed ID: 32087356
[TBL] [Abstract][Full Text] [Related]
14. Ventricular tachycardia in cardiac sarcoidosis: characterization of ventricular substrate and outcomes of catheter ablation.
Kumar S; Barbhaiya C; Nagashima K; Choi EK; Epstein LM; John RM; Maytin M; Albert CM; Miller AL; Koplan BA; Michaud GF; Tedrow UB; Stevenson WG
Circ Arrhythm Electrophysiol; 2015 Feb; 8(1):87-93. PubMed ID: 25527825
[TBL] [Abstract][Full Text] [Related]
15. Percutaneous epicardial ablation of ventricular tachycardia after failure of endocardial approach in the pediatric population with arrhythmogenic right ventricular dysplasia.
Pokushalov E; Romanov A; Turov A; Artyomenko S; Shirokova N; Karaskov A
Heart Rhythm; 2010 Oct; 7(10):1406-10. PubMed ID: 20601157
[TBL] [Abstract][Full Text] [Related]
16. Impact of New Technologies and Approaches for Post-Myocardial Infarction Ventricular Tachycardia Ablation During Long-Term Follow-Up.
Yamashita S; Cochet H; Sacher F; Mahida S; Berte B; Hooks D; Sellal JM; Al Jefairi N; Frontera A; Komatsu Y; Lim HS; Amraoui S; Denis A; Derval N; Sermesant M; Laurent F; Hocini M; Haïssaguerre M; Montaudon M; Jaïs P
Circ Arrhythm Electrophysiol; 2016 Jul; 9(7):. PubMed ID: 27406604
[TBL] [Abstract][Full Text] [Related]
17. Outcomes and ventricular tachycardia recurrence characteristics after epicardial ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy.
Philips B; te Riele AS; Sawant A; Kareddy V; James CA; Murray B; Tichnell C; Kassamali B; Nazarian S; Judge DP; Calkins H; Tandri H
Heart Rhythm; 2015 Apr; 12(4):716-25. PubMed ID: 25530221
[TBL] [Abstract][Full Text] [Related]
18. Ventricular tachycardia in ischemic cardiomyopathy; a combined endo-epicardial ablation as the first procedure versus a stepwise approach (EPILOGUE) - study protocol for a randomized controlled trial.
Hendriks AA; Khan M; Geller L; Kardos A; de Vries LJ; Yap SC; Wijchers SA; Theuns DA; Szili-Torok T
Trials; 2015 Oct; 16():487. PubMed ID: 26514959
[TBL] [Abstract][Full Text] [Related]
19. Endocardial Scar-Homogenization With vs Without Epicardial Ablation in VT Patients With Ischemic Cardiomyopathy.
Mohanty S; Trivedi C; Di Biase L; Burkhardt JD; Della Rocca DG; Gianni C; MacDonald B; Mayedo A; Shetty SS; Zagrodzky W; Baqai F; Bassiouny M; Gallinghouse GJ; Horton R; Al-Ahmad A; Natale A
JACC Clin Electrophysiol; 2022 Apr; 8(4):453-461. PubMed ID: 35246406
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the arrhythmogenic substrate in patients with arrhythmogenic right ventricular cardiomyopathy undergoing ventricular tachycardia ablation.
Kirubakaran S; Bisceglia C; Silberbauer J; Oloriz T; Santagostino G; Yamase M; Maccabelli G; Trevisi N; Della Bella P
Europace; 2017 Jun; 19(6):1049-1062. PubMed ID: 28371837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
